Document is current
Any future updates will be listed below
-
Authors
Hult, Lina
Kylhammar, David
Engvall, Jan
Östgren, Carl Johan
Nyström, Fredrik
Blomstrand, Peter
Hedman, Kristofer
-
Funding
Funding for this research was provided by:
FORSS, the Research Council of Southeastern Sweden (FORSS-968168)
Wallenberg Centre for Molecular Medicine (WCMM) at Linköping University,
ALF-fund (Avtal om Läkarutbildning och Forskning (RÖ-962416, RÖ-926361)
FUTURUM, the County Research Council of Jönköping (FUTURUM-857951)
Linköping University
- License Information
-
More Information
Article History
Received: 14 January 2025
Accepted: 3 June 2025
First Online: 1 September 2025
Declarations
:
: All participants were informed about the study and provided written informed consent. The original study was approved by the Regional Ethical Review Board in Linköping (Diary number: M26-05) and they also approved the extracts from the Swedish national cause-of-death and inpatient registries (diary number: T59-09). The study adheres to the principles of the Declaration of Helsinki and the trial registration number is: ClinicalTrials.gov number NCT01049737 with enrollment date 2005–05.
: Not applicable.
: The authors declare no competing interests.
